Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Non-invasive Biosensors Market, by Technology, (Optical, Transdermal, Thermal, and Others), by Product Type (Glucose Monitoring, Blood Analytes Monitor, and Others), by End User (Hospitals, Diagnostic Lab, Homecare Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 2.7 Bn in 2017 and is expected to exhibit a CAGR of 12.1% over the forecast period (2018-2026).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1704
The increasing number of regulatory approvals for novel non-invasive biosensors is expected to be a major factor that is expected to drive growth of the non-invasive biosensors market over the forecast period. For instance, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device, in 2013. In 2015, Integrity Applications Inc. again received CE approval for its improved version of GlucoTrack DF-F device. The new improved version of GlucoTrack DF-F device has reduced the procedure time from two and half hours to just thirty minutes. Moreover, in 2016, CNOGA Medical Ltd. received approval from Brazilian National Health Surveillance Agency (ANVISA – Agência Nacional de Vigilância Sanitária) to market its new TensorTip COG non-invasive combo Glucometer device in Brazil.
Browse 42 Market Data Tables and 38 Figures spread through 173 Pages and in-depth TOC on Non-invasive Biosensors Market by Technology, (Optical, Transdermal, Thermal, and Others), by Product Type (Glucose Monitors, Blood Analytes Monitors, Breathalyzers, and Others), by End User (Hospitals, Diagnostic Lab, Homecare Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026
To know the latest trends and insights prevalent in the Non-invasive Biosensors Market Press Release, click the link below: https://bit.ly/35iRSny
The increasing R&D activities by key players, in order to gain approval for novel non-invasive biosensors and increasing presence of products in pipeline are the factors that are further expected to drive growth of the market over the forecast period. For instance, in 2017. Mclean Hospital announced about its LabPatch-alcohol, which is a non-invasive skin patch to detect blood alcohol concentrations was in clinical trial.
Moreover, key players in the market are focusing on collaborations and partnerships for distribution of their novel non-invasive biosensors globally. For instance, Integrity Applications Inc. entered into a distribution partnership with MediReva B.V, in 2017. Under the partnership, MediReva B.V. will market Integrity Applications Inc.’s GlucoTrack in the Netherlands. Such strategic collaborations is expected to drive the market growth over the forecast period.
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1704
Key Takeaways of the Global Non-invasive Biosensors Market:
- The global non-invasive biosensors market is expected to exhibit a CAGR of 12.1% over the forecast period (2018-2026). This is attributed to rising number of regulatory approvals of novel non-invasive biosensors. For instance, in 2013, GlucoTrack DF-F received CE marking.
- Among regions, Europe is expected to witness significant growth over the forecast period. This is attributed to increasing regulatory approvals of novel non-invasive biosensors by European Union. For instance, an improved version of GlucoTrack DF-F received CE marking, in 2015.
- Asia Pacific is also expected to exhibit significant growth in the global non-invasive biosensor market, attributed to rising prevalence of diabetes in the region, which is expected to drive demand for novel diagnosis methods such as non-invasive glucometers. For instance, according to the Indian Diabetes Research Foundation, 2016, around 60% of the global population suffering from diabetes lives in Asia pacific, with around one-half in China and India combined. Moreover, it states that Western Pacific reported over 138.2 million people suffered from diabetes in 2016, and the number h is expected to rise to 201.8 million by 2035.
- Key players operating in the non-invasive biosensors market include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc., and Abbott Laboratories.
Request a sample to stay abreast on the key trends impacting this market: https://www.coherentmarketinsights.com/insight/request-sample/1704
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027